Abstract
Glioblastoma multiforme (GBM) is one of the most aggressive tumor types, with a median survival time of 15 months. Furthermore, current treatments are not able to prevent tumor recurrence in most cases. Understanding basic aspects of tumor biology, such as its origin, development and resistance is crucial to develop more effective therapies. RNA binding proteins (RBPs) are among the molec…